Judge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney...
Judge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney Lied
View ArticleJudge Allows More Evidence in Gilead-Merck Patent Dispute
Judge Allows More Evidence in Gilead-Merck Patent Dispute
View ArticleJudge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney...
Judge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney Lied -- Update
View ArticleIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
Ionis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
View ArticleIonis Pharmaceuticals Inc. (IONS) Is Sinking After GSK Decides Against Phase 3
Ionis Pharmaceuticals Inc. (IONS) Is Sinking After GSK Decides Against Phase 3
View ArticleIonis's Shares Fall After Co-Developer Opts Against a Late-Stage Trial -- 2nd...
Ionis's Shares Fall After Co-Developer Opts Against a Late-Stage Trial -- 2nd Update
View ArticleStocks Nearly Flat After Recovering From Early Weakness - U.S. Commentary
Stocks Nearly Flat After Recovering From Early Weakness - U.S. Commentary
View ArticleJudge Sides With Gilead Against Merck in Case Over Hepatitis C Drug Patents
Judge Sides With Gilead Against Merck in Case Over Hepatitis C Drug Patents
View ArticleJudge Sides With Gilead Against Merck in Hepatitis C Case
Judge Sides With Gilead Against Merck in Hepatitis C Case
View ArticleJudge Sides With Gilead in Drug-Patent Dispute -- WSJ
Judge Sides With Gilead in Drug-Patent Dispute -- WSJ
View ArticleStocks Remain Firmly Positive Following Early Jump - U.S. Commentary
Stocks Remain Firmly Positive Following Early Jump - U.S. Commentary
View ArticleBargain Hunting Leads To Substantial Rebound On Wall Street - U.S. Commentary
Bargain Hunting Leads To Substantial Rebound On Wall Street - U.S. Commentary
View ArticleIonis Pharmaceuticals Inc. (IONS) Has Broken Out Into Positive Territory
Ionis Pharmaceuticals Inc. (IONS) Has Broken Out Into Positive Territory
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Move Modestly Lower As Initial Buying Interest Fades - U.S. Commentary
Stocks Move Modestly Lower As Initial Buying Interest Fades - U.S. Commentary
View ArticleSCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX
SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX
View ArticleBiogen, Ionis: Nusinersen Meets Primary Endpoint At Interim Analysis Of Trial
Biogen, Ionis: Nusinersen Meets Primary Endpoint At Interim Analysis Of Trial
View ArticleStocks May Move Modestly Higher In Early Trading - U.S. Commentary
Stocks May Move Modestly Higher In Early Trading - U.S. Commentary
View Article